Abstract:The two main pathological hallmarks of Parkinson's disease are loss of dopamine neurons in the substantia nigra pars compacta and proteinaceous amyloid fibrils composed mostly of α-synuclein, called Lewy pathology. Levodopa to enhance dopaminergic transmission remains one of the most effective treatment for alleviating the motor symptoms of Parkinson's disease (Olanow, Mov Disord 34:812-815, 2019). In addition, deep brain stimulation (Bronstein et al., Arch Neurol 68:165, 2011) to modulate basal ganglia circuit activity successfully alleviates some motor symptoms. MRI guided focused ultrasound in the subthalamic nucleus is a promising therapeutic strategy as well (Martinez-Fernandez et al., Lancet Neurol 17:54-63, 2018). However, to date, there exists no treatment that stops the progression of this disease. The findings that α-synuclein can be released from neurons and inherited through interconnected neural networks opened the door for discovering novel treatment strategies to prevent the formation and spread of Lewy pathology with the goal of halting PD in its tracks. This hypothesis is based on discoveries that pathologic aggregates of α-synuclein induce the endogenous α-synuclein protein to adopt a similar pathologic conformation, and is thus self-propagating. Phase I clinical trials are currently ongoing to test treatments such as immunotherapy to prevent the neuron to neuron spread of extracellular aggregates. Although tremendous progress has been made in understanding how Lewy pathology forms and spreads throughout the brain, cell intrinsic factors also play a critical role in the formation of pathologic α-synuclein, such as mechanisms that increase endogenous α-synuclein levels, selective expression profiles in distinct neuron subtypes, mutations and altered function of proteins involved in α-synuclein synthesis and degradation, and oxidative stress. Strategies that prevent the formation of pathologic α-synuclein should consider extracellular release and propagation, as well as neuron intrinsic mechanisms.

Aggregation and phase separation of α-synuclein in Parkinson's disease

Liquid-liquid phase separation and liquid-to-solid transition mediate α-synuclein amyloid fibril containing hydrogel formation

Liquid–liquid phase separation and conformational strains of α-Synuclein: implications for Parkinson's disease pathogenesis

α-Synuclein aggregation nucleates through liquid–liquid phase separation

Structure, Distribution, and Genetic Profile of Α-Synuclein and Their Potential Clinical Application in Parkinson's Disease.

β-synuclein regulates the phase transitions and amyloid conversion of α-synuclein

Phase Separation and Aggregation of α-Synuclein Diverge at Different Salt Conditions

Liquid-Liquid Phase Separation Promotes Protein Aggregation and Its Implications in Ferroptosis in Parkinson's Disease Dementia

Initiation and propagation of α-synuclein aggregation in the nervous system

Protein–protein interactions regulating α-synuclein pathology

[Alpha-synuclein interacted proteins: the relevance with the pathogenesis of Parkinson's disease].

Prion-Like Mechanisms in Parkinson’s Disease

The Disordered Protein SERF Promotes Α-Synuclein Aggregation Through Liquid-Liquid Phase Separation

Conformational change of α-synuclein fibrils in cerebrospinal fluid from different clinical phases of Parkinson's disease

alpha-synuclein, autophagy-lysosomal pathway, and Lewy bodies: mutations, propagation, aggregation, and the formation of inclusions

α-Synuclein Oligomers Displace Monomeric α-Synuclein from Lipid Membranes

Calcium promotes α-synuclein liquid-liquid phase separation to accelerate amyloid aggregation

Parkinson’s disease is a type of amyloidosis featuring accumulation of amyloid fibrils of α-synuclein

⍺-Synuclein levels in Parkinson's disease - Cell types and forms that contribute to pathogenesis

Exploring α-synuclein Interaction Partners and their Potential Clinical Implications for Parkinson's Disease

Amyloid Aggregation and Liquid-Liquid Phase Separation from the Perspective of Phase Transitions